Tg(HBA-CD59*H44Q)1Jha
Transgene Detail
|
Symbol: |
Tg(HBA-CD59*H44Q)1Jha |
Name: |
transgene insertion 1, Jose A Halperin |
MGI ID: |
MGI:6376204 |
Synonyms: |
hCD59H44Q |
Transgene: |
Tg(HBA-CD59*H44Q)1Jha Location: unknown
|
Alliance: |
Tg(HBA-CD59*H44Q)1Jha page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(HBA-CD59*H44Q)1Jha expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
CD59 (966) |
|
contains a H44Q amino acid substitution |
|
|
|
Mutation details: The ~7 kb transgene is designed with the human locus control region (LCR) and the alpha globin (HBA) gene promoter driving expression of mutant human CD59 antigen (CD59) cDNA. hCD59 was modified to harbor a histidine to glutamine substitution at amino acid 44 (H44Q).
(J:280723)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:280723 Sahoo R, et al., A distinctive histidine residue is essential for in vivo glycation-inactivation of human CD59 transgenically expressed in mice erythrocytes: Implications for human diabetes complications. Am J Hematol. 2017 Nov;92(11):1198-1203 |
All: |
1 reference(s) |
|